Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1
- Conditions
- Tobacco Use Disorder
- Registration Number
- NCT00067158
- Lead Sponsor
- New York University
- Brief Summary
The purpose of this study is to look at how feasible it is to incorporate a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and its impact on substance abuse and cigarette smoking.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 585
- Patient is alcohol or drug dependent, in Outpatient Drug-Free or Opiate Substitute program and is interested in quitting smoking
- Patient is psychotic
- Use of smokeless tobacco
- Use of other smoking cessasation product
- Pregnancy
- Patient has hyper-tension, heart problems, or skin condition
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Drug use Smoking Cessation
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (13)
Matrix Institute on Addictions
🇺🇸Los Angeles, California, United States
Tarzana Treatment Center
🇺🇸Tarzana, California, United States
SPECTRUM
🇺🇸Miami, Florida, United States
Center for Drug Free Living
🇺🇸Orlando, Florida, United States
Chelsea Arbor Addictions Treatment Center
🇺🇸Ann Arbor, Michigan, United States
Psychiatry and Behavioral Medicine Professionals I
🇺🇸Detroit, Michigan, United States
Narco Freedom (Bridge Plaza)
🇺🇸Long Island City, New York, United States
St. Luke's Roosevelt Hospital Center
🇺🇸New York, New York, United States
St. Luke's Roosevelt Hospital Center, Womens
🇺🇸New York, New York, United States
Mount Sinai Medical Center
🇺🇸New York, New York, United States
Scroll for more (3 remaining)Matrix Institute on Addictions🇺🇸Los Angeles, California, United States